Rocket Lab USA, Embraer, RTX and Leidos are included in this Analyst Blog.

Google Maps has changed the name of the Gulf of Mexico, to the Gulf of America, after Donald Trump passed an executive order renaming the body of water in the eyes of the US.

Powell's testimony may impact S&P 500, gold, and Treasury yields as traders watch for signals on inflation, rate cuts, and tariff risks ahead of CPI data.

The report provides a detailed data-centric analysis of the loyalty market opportunities and risks across a range of end-use sectors and market segments in Brazil. With over 50 KPIs at the country level, this report provides a comprehensive understanding of loyalty market dynamics, market size and forecast, and market share statistics. The report provides a detailed data-centric analysis of the loyalty market opportunities and risks across a range of end-use sectors and market segments in Brazil. With over 50 KPIs at the country level, this report provides a comprehensive understanding of loyalty market dynamics, market size and forecast, and market …

Refiner Phillips 66 is the latest target of activist investor Elliott Management that is aggressively pursuing companies in the energy space.

Tobacco giant Altria Group (MO 2.24%), a traditionally slow and stodgy stock, saw its share price soar nearly 30% in 2024, and that increase doesn't include the stock's legendary, high-yield dividend (total return was 41%). The company, best known for selling Marlboro cigarettes in the United States, is has a solid following in the dividend investing community.

Axsome (AXSM) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Vanguard recently executed its largest cut to investment fees in its roughly five-decade existence. The largest investment management firm in the world lowered the expense ratio on 168 of its mutual funds and exchange-traded funds (ETFs).

Q3 results showed revenue up 34% year over year, coupled with strong overall profitability, both benefiting from higher incentive fees. Underlying growth in assets under management/advisement was muted, up just 6% year over year. While growth is expected to slowdown in the coming quarters, shares remain richly valued at 34.6 times earnings.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=128707&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Applied Therapeutics, Inc. (NASDAQ:APLT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/applied-therapeutics-inc-lawsuit-submission-form?prid=128702&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Neumora Therapeutics, Inc. (NASDAQ:NMRA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/neumora-therapeutics-inc-lawsuit-submission-form?prid=128703&wire=1 or contact Joseph E. Levi, Esq.

Nike (NKE 3.29%) and Apple (AAPL 0.12%) are often considered stable blue chip stocks for conservative investors. They're two of the most iconic American brands, they have plenty of pricing power, and they lead their respective markets.

Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 February 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Jan De Witte as Operating Partner. Jan is an accomplished senior executive with extensive experience leading international growth and transformation for global technology and life sciences companies.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your ModivCare Inc. (NASDAQ:MODV) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/modivcare-inc-lawsuit-submission-form?prid=128706&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Napco Security Technologies, Inc. ("Napco Security Technologies, Inc.") (NASDAQ:NSSC) concerning possible violations of federal securities laws. On February 3, 2025, news website Investing.com published an article entitled "NAPCO Security stock tumbles after Q2 sales decline.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Grocery Outlet Holding Corp. (NASDAQ:GO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/grocery-outlet-holding-corp-lawsuit-submission-form?prid=128698&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your Monolithic Power Systems Inc. (NASDAQ:MPWR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/monolithic-lawsuit-submission-form?prid=128696&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Venture Global, Inc. ("Venture Global, Inc.") (NYSE:VG) concerning possible violations of federal securities laws. Venture Global conducted its initial public offering of 70 million shares priced at $25.00 per share on or around January 24, 2025.

NEW YORK, NY / ACCESS Newswire / February 11, 2025 / If you suffered a loss on your ESSA Pharma Inc. (NASDAQ:EPIX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/essa-pharma-inc-lawsuit-submission-form?prid=128704&wire=1 or contact Joseph E. Levi, Esq.